MedPath

Technetium Tc-99m pertechnetate

Generic Name
Technetium Tc-99m pertechnetate
Drug Type
Small Molecule
Chemical Formula
H8O4Tc
CAS Number
23288-61-1
Unique Ingredient Identifier
PPP8783IQ1

Overview

Technetium Tc-99m pertechnetate is a radiopharmaceutical diagnostic agent composed of an oxoanion with the chemical formula TcO4-. Pertechnetate has a wide variety of uses within nuclear medicine as it distributes within the body to a similar extent as iodine. It also concentrates in the thyroid gland, salivary glands, gastric mucosa, and choroid plexus. However, in contrast to the iodide ion, the pertechnetate ion is released unchanged from the thyroid gland. Currently marketed as the product Drytec, technetium-99m pertechnetate is indicated for imaging of the following tissues: thyroid, salivary gland, urinary bladder (for detection of vesico-ureteral reflux), and the nasolacrimal drainage system. Technetium-99m's short half life (6 hours) makes storage impossible, therefore it is supplied as its parent nuclide molybdenum-99, which spontaneously decays to technetium-99 through beta decay. This is normally supplied in a hospital setting through the use of a technetium-99m generator, whereby technetium exits the generator in the form of the pertechnetate ion, TcO4−, which can be extracted and promptly used for clinical diagnostics. Following intravenous injection, single photon emission computed tomography (SPECT) is performed to detect the gamma ray emmitted by the decay of Technetium-99m to Technetium-99.

Indication

Sodium Pertechnetate Tc99m Injection is indicated for use in adults for imaging in the following tissues: thyroid, salivary gland, urinary bladder (for detection of vesico-ureteral reflux), and nasolacrimal drainage system (dacryoscintigraphy). It is indicated for use in children for imaging the following tissues: thyroid and urinary bladder.

Associated Conditions

  • Vesicoureteral Reflux (VUR)

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
Curium US LLC
69945-035
INTRAVENOUS
3.5 Ci in 1 1
6/9/2022
Lantheus Medical Imaging, Inc.
11994-090
INTRAVENOUS
250 mCi in 1 mL
1/31/2023
Lantheus Medical Imaging, Inc.
11994-091
INTRAVENOUS
250 mCi in 1 mL
1/31/2023
Curium US LLC
69945-025
INTRAVENOUS
2.5 Ci in 1 1
6/9/2022
Curium US LLC
69945-010
INTRAVENOUS
1 Ci in 1 1
6/9/2022
Curium US LLC
69945-110
INTRAVENOUS
11 Ci in 1 1
6/9/2022
Curium US LLC
69945-015
INTRAVENOUS
1.5 Ci in 1 1
6/9/2022
Curium US LLC
69945-030
INTRAVENOUS
3 Ci in 1 1
6/9/2022
Curium US LLC
69945-160
INTRAVENOUS
16 Ci in 1 1
6/9/2022
Curium US LLC
69945-140
INTRAVENOUS
14 Ci in 1 1
6/9/2022

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
GENTECH MOLYBDENUM (99Mo) / TECHNETIUM (99mTc) STERILE GENERATOR
SIN16108P
INJECTION, SOLUTION (RADIOPHARMACEUTICAL)
15.92/ 23.88/31.84/39.80/47.76/63.68/79.61/95.53 GBq
2/24/2021
TEKCIS RADIONUCLIDE GENERATOR 2-50 GBQ
SIN15741P
GENERATOR
2/4/6/8/10/12/16/20/25/50 GBq
7/10/2019
UltraTechneKow FM Generator
SIN14082P
SOLUTION
2.08,4.16,6.24,8.32,10.4,12.47,16.63,20.79,24.95,29.11,33.26,41.58 (Gbq)
1/19/2012

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.

Health Canada Drug Approvals

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
No Health Canada approvals found for this drug.

CIMA AEMPS Drug Approvals

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.